Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men - 10/10/20
Doi : 10.1016/j.jaad.2020.03.002
Amy J. Petty, BS a, Adela R. Cardones, MD, MHSc b, c, Anne L. Marano, MD b, ⁎ 
a School of Medicine, Duke University, Durham, North Carolina
b Department of Dermatology, Duke University, Durham, North Carolina
c Department of Dermatology, Durham Veterans Affairs Medical Center, Durham, North Carolina
∗Correspondence to: Anne L. Marano, MD, 234 Crooked Creek Parkway, Ste 300, Durham, NC 27713234 Crooked Creek ParkwaySte 300DurhamNC27713
| Funding sources: None. |
|
| Disclosure: Dr Anne Marano is a principal investigator for a study for Viela Bio, a phase I trial of VIB7734 in patients with systemic lupus erythematosus, cutaneous lupus erythematosus, Sjögren syndrome, systemic sclerosis, polymyositis, and dermatomyositis. MS Petty and Dr Cardones have no conflicts of interest to declare. |
|
| IRB approval status: Reviewed and approved by the Duke University IRB (approval 00084622). |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 5
P. 1455-1457 - novembre 2020 Retour au numéro
Article précédent
- Dermatologists in social media: A study on top influencers, posts, and user engagement
- Tiffany J. Sierro, Paulina M. Young, Sophia K. Kassabian, Kevin K. Wu, April W. Armstrong
- A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone
- Ileana E. Arreola Jauregui, Gabriel Huerta Rivera, Manuel Soria Orozco, Silvia Meyer-Nava, Juan E. Paniagua Santos, Juan B. López Zaldo, Ilse Meyer-Nava, Clara Madrid Carrillo, Iara E. Zaldo Rolón, Aline E. Baeza Echeverría, Minerva Vázquez Huerta
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?